Scoggin Management LP Clene Inc. Transaction History

Scoggin Management LP

  • $394 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.31 - $0.44 $38,750 - $55,000
-125,000 Reduced 25.0%
375,000 $135,000
Q1 2024

May 15, 2024
SELL
$0.28 - $0.53 $70,000 - $132,500
-250,000 Reduced 33.33%
500,000 $215,000
Q3 2023

Nov 14, 2023
BUY
$0.46 - $0.87 $115,000 - $217,500
250,000 Added 50.0%
750,000 $375,000
Q2 2023

Aug 14, 2023
BUY
$0.78 - $1.22 $390,000 - $610,000
500,000 New
500,000 $440,000

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $262M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Scoggin Management LP Portfolio

Follow Scoggin Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scoggin Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Scoggin Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email